TOS.TO - TSO3 Inc.

Toronto - Toronto Delayed Price. Currency in CAD
1.29
+0.01 (+0.78%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close1.28
Open1.28
Bid1.29 x 0
Ask1.32 x 0
Day's Range1.25 - 1.31
52 Week Range1.25 - 3.32
Volume211,300
Avg. Volume232,718
Market Cap119.782M
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)-0.09
Earnings DateMar 19, 2018 - Mar 23, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est1.80
  • ACCESSWIRE4 days ago

    Today’s Research Reports on Canopy Growth, Fennec Pharmaceuticals, Neptune Technologies & Bioressources and TSO3

    NEW YORK, NY / ACCESSWIRE / February 22, 2018 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register ...

  • PR Newswire11 days ago

    TSO3 to Present at the RBC Capital Markets Healthcare Conference

    QUEBEC CITY and MYRTLE BEACH, SC, Feb. 14, 2018 /PRNewswire/ - TSO3 Inc. (TOS.TO), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, today announced the Company will participate in the RBC Capital Markets Healthcare Conference in New York, New York. TSO3's management is scheduled to present on Thursday, February 22, 2018 at 1:35 PM EST. An audio webcast of the Company's presentation will be available in the investor relations section of TSO3's website at www.tso3.com.

  • CNW Group11 days ago

    TSO3 to Present at the RBC Capital Markets Healthcare Conference

    TSO3 to Present at the RBC Capital Markets Healthcare Conference

  • February Growth Stocks To Look Out For
    Simply Wall St.17 days ago

    February Growth Stocks To Look Out For

    High growth companies such as Kirkland Lake Gold and Pan American Silver has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of theseRead More...

  • PR Newswirelast month

    IIROC Trade Resumption - TOS

    TORONTO , Jan. 25, 2018 /CNW/ - Trading resumes in: Company: TSO3 Inc. TSX Symbol: TOS (all issues) Resumption (ET): 10:45 AM IIROC can make a decision to impose a temporary suspension (halt) of trading ...

  • CNW Grouplast month

    IIROC Trade Resumption - TOS

    IIROC Trade Resumption - TOS

  • Newsfilelast month

    IIROC Trade Resumption - TSO3 Inc.

    Toronto, Ontario--(Newsfile Corp. - January 25, 2018) - Trading resumes in: Company: TSO3 Inc. TSX Symbol: TOS (all issues) ...

  • PR Newswirelast month

    TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America

    QUEBEC CITY and MYRTLE BEACH, SC, Jan. 25, 2018 /PRNewswire/ - TSO3 Inc. (TOS.TO), ("TSO3" or the "Company"), an innovator in sterilization technology for medical devices in healthcare settings, announced today that, in a joint effort to increase sales to end users and optimize the customer experience, it has entered into a new agreement (the "Sales and Repurchase Agreement") with Getinge Infection Control AB, its global distribution partner. The Sales and Repurchase Agreement allows the Company to sell its STERIZONE® VP4 Sterilizers and associated products and services directly into the United States and Canada and repurchase not less than 100 STERIZONE® VP4 sterilizers for $3.3 million, with an initial order of 30 units. Getinge will continue to sell its inventory in North America and the rest of the world and the parties have agreed to a customer selection mechanism to prevent the likelihood of channel conflict.

  • CNW Grouplast month

    TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America

    TSO3 and Global Distributor Agree on Co-Commercial Strategy for North America

  • CNW Grouplast month

    IIROC Trading Halt - TOS

    IIROC Trading Halt - TOS

  • PR Newswirelast month

    IIROC Trading Halt - TOS

    TORONTO , Jan. 25, 2018 /CNW/ - The following issues have been halted by IIROC: Company: TSO3 Inc. TSX Symbol: TOS (all issues) Reason: Pending News Halt Time (ET): 9:42 AM IIROC can make a decision to ...

  • Newsfilelast month

    IIROC Trade Halt - TSO3 Inc.

    Toronto, Ontario--(Newsfile Corp. - January 25, 2018) - The following issues have been halted by IIROC: Company:  TSO3 Inc. TSX Symbol: TOS (all issues) ...

  • CNW Grouplast month

    TSO3 Provides an Operational Update

    TSO3 Provides an Operational Update

  • PR Newswirelast month

    TSO3 Provides an Operational Update

    QUEBEC CITY and MYRTLE BEACH, SC , Jan. 25, 2018 /PRNewswire/ - TSO 3 Inc. (TSX: TOS) ("TSO 3 " or the "Company"), an innovator in sterilization technology for medical devices in healthcare ...

  • December Growth Stock Opportunities
    Simply Wall St.2 months ago

    December Growth Stock Opportunities

    Companies such as Alaris Royalty and Avino Silver & Gold Mines have a significantly positive future outlook on the basis of their profitability and returns. Investors seeking to enhance theirRead More...

  • PR Newswire2 months ago

    TSO3 Provides Duodenoscope Regulatory Filing Update

    QUEBEC CITY and MYRTLE BEACH, SC, Dec. 19, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has had further dialogue with US Regulators in connection with their recent request for additional information (AI) regarding the Company's submission to extend claims of its STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes. "We continue to work productively with US regulators in pursuit of this new indication for use of our sterilizer," stated Ric (R.M.) Rumble, President and CEO of TSO3 Inc.  "The Company has continued its testing and data compilation to further support our claims as a natural part of our internal processes.

  • CNW Group2 months ago

    TSO3 Provides Duodenoscope Regulatory Filing Update

    TSO3 Provides Duodenoscope Regulatory Filing Update

  • PR Newswire3 months ago

    TSO3 Announces the Death of Mr. Jean Lamarre

    QUEBEC CITY and MYRTLE BEACH, FL, Nov. 27, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, sadly announced the death of Mr. Jean Lamarre, a member of the Board of Directors of TSO3.  Mr. Lamarre contributed sound and constructive counsel on TSO3's Board of Directors, and while leading TSO3's Human Resources Committee. Mr. Lamarre was a pillar of the Canadian business community, holding several board positions, including the position of Board Chair for SEMAFO, and various other positions of significant responsibility with Groupe Lavalin and numerous other organizations.

  • CNW Group3 months ago

    TSO3 Announces the Death of Mr. Jean Lamarre

    TSO3 Announces the Death of Mr. Jean Lamarre

  • Growth Stocks Investors Love
    Simply Wall St.3 months ago

    Growth Stocks Investors Love

    High growth companies such as Canopy Growth and Aurinia Pharmaceuticals has a positive future outlook in terms of their returns, profitability and cash flows. The prospects of these companies tendRead More...

  • CNW Group3 months ago

    TSO3 Provides Duodenoscope Regulatory Filing Update

    TSO3 Provides Duodenoscope Regulatory Filing Update

  • PR Newswire3 months ago

    TSO3 Provides Duodenoscope Regulatory Filing Update

    QUEBEC CITY and MYRTLE BEACH, SC, Nov. 16, 2017 /PRNewswire/ - TSO3 Inc. (TOS.TO), an innovator in sterilization technology for medical devices in healthcare settings, announced today that it has responded to the recent request for additional information (AI), from the U.S. Food and Drug Administration. This information is in support of the Company's submission to extend claims of its innovative STERIZONE® VP4 Sterilizer to include terminal sterilization of duodenoscopes. The Company's response includes a summary of results from tests evaluating the effect of TSO3's sterilization process on specific features incorporated in the design of identified scopes, as well as additional labeling targeted at a selected duodenoscope.

  • TSO3, Inc. :TOS-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017
    Capital Cube4 months ago

    TSO3, Inc. :TOS-CA: Earnings Analysis: Q3, 2017 By the Numbers : November 9, 2017

    Categories: Yahoo FinanceGet free summary analysis TSO3, Inc. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of TSO3, Inc. – Invacare Corporation and Alpha Pro Tech, Ltd. (IVC-US and APT-US) that have also reported for this period. Highlights Summary numbers: Revenues of CAD 6.40 million, Net ... Read more (Read more...)